Survivorship

Dr. Alexandra Zaleta discusses how most cancer patients face prior authorization delays, despite 95% being approved, highlighting the need for reform.

Diagnosed with incurable cancer in her 20s, Nathalie Jean rebuilt broken systems in public service — only to face wage theft and silence after success.

CURE asked cancer survivors, thrivers, advocates, and those whose lives have been touched by cancer: what does National Cancer Survivors Month mean to you?

At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of resilience and quiet hope.

I share how hope, even when uncertain, helped me through cancer and honors its role in balancing realism, resilience and emotional survival.

Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.

After having a double mastectomy to rid myself of cancer, I’m less picky about how I look and won’t be wearing uncomfortable shapewear for a wedding.

Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.

The START Hope Hub is a robust digital platform designed to break down barriers to early-phase clinical trial access for those with cancer.

A study explores how prior authorization requirements; coverage stoppages and other red tape can generate barriers to life saving therapies in cancer care.

Survivorship after cancer can be harder than treatment. My daughter faces lasting side effects, fear, and uncertainty while building a life she hopes to live fully.

Being a cancer survivor for nine and a half years has taught me to live in the moment, to make those moments count.

Patients can prepare for self-advocacy by bringing personal overviews to help care teams connect with them as individuals, explained Michelle Kirschner.

Five years after my transplant for leukemia, I’m learning to focus on gratitude despite daily struggles, remembering that being alive is the greatest gift.

Michelle Kirschner discusses the how patients can foster a strong network of supporters from diagnosis through survivorship.

Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among young women with cancer.

When it comes to living with cancer, your nurses make a difference.

It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden both before and after treatment.

Natalie Schnaitmann discusses urgent supportive care gaps younger women with cancer encounter, and how they affect long-term quality of life.

Natalie Schnaitmann discusses urgent supportive care gaps that affect long-term quality of life for younger women with cancer.

I’m here to prove that powerful phrase; after nearly 16 years living with incurable cancer, I know there’s more to my story than the statistics.

Participation in a structured exercise program following surgery and adjuvant chemo improved key survival end points in stage 3 and high-risk stage 2 CRC.

There are many instances where teddy bears can be the key to opening hearts and minds during cancer care.

Christine Simonelli, B.S.N., RN, CCRC, OCN, is amazing, and goes out of her way to help patients and providers.

Kathleen Shuey, M.S., RN, SCON, ACNS-BC, listens and guides us in the right direction in caring for our oncology population.

Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.

CURE spoke with experts about what life is like for patients in the survivorship care period.

As a Lynch syndrome previvor, I feel deep gratitude to witness my son’s graduation — a milestone my brother never lived to see with his own child.

Dr. Kara Kelly discusses specific long-term health considerations that AYA survivors of lymphoma should be aware of to best prepare for survivorship.

Researchers followed patients for years and found that the risk of dying from prostate cancer depended on how aggressive the cancer was at diagnosis.